CClinicalTrials.gg
Status unknownNCT057392403PASUpdated Mar 1, 2023

Effects of Preoperative 3D Printing of Distal Intra-articular Radius Fractures on Quality of Fracture Reduction

An interventional study of Osteosynthesis in Distal Radius Fracture and 3D Printing, sponsored by Vilijam Zdravkovic. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-01.

Sponsored by Vilijam Zdravkovic · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators aim to evaluate the effect of a preoperative 3D printed Model (3PAS) of distal intraarticular radius fractures on quality of fracture reduction. Surgical procedure is equal in the 3PAS and in the conventional group. To evaluate the quality of fracture reduction each patient receives a postoperative CAT-scan.

02

Conditions studied

  • Distal Radius Fracture
  • 3D Printing
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 80 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

This is the only study on the registry with Vilijam Zdravkovic as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patient older than 18 years
  • Surgery criteria fulfilled
  • Informed consent
  • Intra-articular Fracture of the distal radius (AO 23-B and 23-C) (also including Avulsion of the processus styloideus ulnae AO/OTA 2U3A1.1) in preoperative CAT-Scan

Exclusion criteria

Exclusion Criteria:

  • Patient does not want a surgical treatment
  • Patient does not want to participate
  • Positive history for surgery due to injury of the hurt wrist beforehand
  • Positive history for surgery due to injury of the opposite wrist beforehand
  • Additional injuries to the hand and forearm (except distal ulna fracture AO 2U3A1.1)
  • Pregnancy
  • Vulnerable people
  • Distal ulna fracture (except AO 2U3A1.1)
  • Extraarticular radius fracture (AO 23-A)
  • Concomitant injuries which interfere with the planned aftercare (intubated for a long time, additional elbow or shoulder fracture)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Other
    no 3D model

    Procedure: Osteosynthesis

  • Other
    3D model

    Procedure: Osteosynthesis

Interventions

  • ProcedureOsteosynthesis

    Osteosynthesis of distal radius fractures

06

What researchers measure

Primary outcomes

  1. Articular step-off of the distal radius joint surface in the postop CAT-scan

    Time frame: 6 weeks

  2. Articular gap of the distal radius joint surface in the postop CAT-scan

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05739240
Lead sponsor
Vilijam Zdravkovic
Responsible party
Vilijam Zdravkovic (Principal investigator, Cantonal Hospital of St. Gallen) — Sponsor-investigator
First posted
Feb 22, 2023
Start date
Mar 1, 2023 (estimated)
Primary completion
Mar 31, 2024 (estimated)
Completion
Mar 31, 2025 (estimated)
Last update
Mar 1, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion